Qiang Wang (Q Wang)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Topics

Multiple Myeloma

Cell Cycle Arrest

Inflammatory Response

Ejection Fraction

Top Venues

Nature communications

Science signaling

This page only lists publications with an associated author ORCID identifier.

Publications

Miao Xian, Qiang Wang, Liuling Xiao, Ling Zhong, Wei Xiong, Lingqun Ye, Pan Su, Chuanchao Zhang, Yanqiang Li, Robert Z Orlowski, Fenghuang Zhan, Siddhartha Ganguly, Youli Zu, Jianfei Qian, Qing Yi
Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis. Nature communications 15 (1) (2024)
Miao Xian, Qiang Wang, Liuling Xiao, Ling Zhong, Wei Xiong, Lingqun Ye, Pan Su, Chuanchao Zhang, Yanqiang Li, Robert Z Orlowski, Fenghuang Zhan, Siddhartha Ganguly, Youli Zu, Jianfei Qian, Qing Yi
Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis. Nature communications 15 (1) (2024)
Miao Xian, Qiang Wang, Liuling Xiao, Ling Zhong, Wei Xiong, Lingqun Ye, Pan Su, Chuanchao Zhang, Yanqiang Li, Robert Z Orlowski, Fenghuang Zhan, Siddhartha Ganguly, Youli Zu, Jianfei Qian, Qing Yi
Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis. Nature communications 15 (1) (2024)
Miao Xian, Qiang Wang, Liuling Xiao, Ling Zhong, Wei Xiong, Lingqun Ye, Pan Su, Chuanchao Zhang, Yanqiang Li, Robert Z Orlowski, Fenghuang Zhan, Siddhartha Ganguly, Youli Zu, Jianfei Qian, Qing Yi
Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis. Nature communications 15 (1) (2024)
Miao Xian, Qiang Wang, Liuling Xiao, Ling Zhong, Wei Xiong, Lingqun Ye, Pan Su, Chuanchao Zhang, Yanqiang Li, Robert Z Orlowski, Fenghuang Zhan, Siddhartha Ganguly, Youli Zu, Jianfei Qian, Qing Yi
Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis. Nature communications 15 (1) (2024)
Hongmei Luo, Dan Zhang, Fangfang Wang, Qiang Wang, Yu Wu, Maling Gou, Yiguo Hu, Wenyan Zhang, Jingcao Huang, Yuping Gong, Ling Pan, Tianshu Li, Pan Zhao, Danfeng Zhang, Ying Qu, Zhigang Liu, Tao Jiang, Yang Dai, Tingting Guo, Jiang Zhu, Lingqun Ye, Li Zhang, Weiping Liu, Qing Yi, Yuhuan Zheng
ALCAM-EGFR interaction regulates myelomagenesis. Blood advances 5 (23) (2022)
Qiang Wang, Zhijuan Lin, Zhuo Wang, Lingqun Ye, Miao Xian, Liuling Xiao, Pan Su, Enguang Bi, Yung-Hsing Huang, Jianfei Qian, Lintao Liu, Xingzhe Ma, Maojie Yang, Wei Xiong, Youli Zu, Sai Ravi Pingali, Bing Xu, Qing Yi
RARγ activation sensitizes human myeloma cells to carfilzomib treatment through OAS-RNase L innate immune pathway. Blood (2021)
Jing Yang, Zhiqiang Liu, Huan Liu, Jin He, Jianling Yang, Pei Lin, Qiang Wang, Juan Du, Wencai Ma, Zheng Yin, Richard Eric Davis, Robert Z Orlowski, Jian Hou, Qing Yi
C-reactive protein promotes bone destruction in human myeloma through the CD32-p38 MAPK-Twist axis. Science signaling 10 (509) (2017)
Qiang Wang, Y Lu, R Li, Y Jiang, Y Zheng, J Qian, E Bi, C Zheng, J Hou, S Wang, Q Yi
Therapeutic effects of CSF1R-blocking antibodies in multiple myeloma. Leukemia 32 (1) (2017)
Enguang Bi, Xingzhe Ma, Yong Lu, Maojie Yang, Qiang Wang, Gang Xue, Jianfei Qian, Siqing Wang, Qing Yi
Foxo1 and Foxp1 play opposing roles in regulating the differentiation and antitumor activity of TH9 cells programmed by IL-7. Science signaling 10 (500) (2017)